AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 271: H602-H613, 1996;
0363-6135/96 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kunert, M. P.
Right arrow Articles by Abraham, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kunert, M. P.
Right arrow Articles by Abraham, D. J.

AJP - Heart and Circulatory Physiology, Vol 271, Issue 2 602-H613, Copyright © 1996 by American Physiological Society


ARTICLES

RSR-13, an allosteric effector of hemoglobin, increases systemic and iliac vascular resistance in rats

M. P. Kunert, J. F. Liard and D. J. Abraham
Department of Physiology, Medical College of Wisconsin, Milwaukee 53226, USA.

Tissue O2 delivery in excess of metabolic demand may be a factor in the development of high vascular resistance in experimental models of volume-expanded hypertension. This hypothesis was previously tested in rats with an exchange transfusion of red blood cells treated with inositol hexaphosphate or an intravenous infusion of RSR-4, allosteric effectors of hemoglobin. The binding of these drugs with hemoglobin effect a conformational change in the molecule, such that the affinity for O2 is reduced. However, in both preparations, the changes in vascular resistance could have been nonspecific. The present studies used intravenous infusions of RSR-13, which did not share some of the problematic characteristics of RSR-4 and inositol hexaphosphate. Conscious instrumented rats (an electromagnetic flow probe on ascending aorta or an iliac, mesenteric, or renal Doppler flow probe) were studied for 6 h after an RSR-13 infusion of 200 mg/kg in 15 min. This dose significantly increased arterial P50 (PO2 at which hemoglobin is 50% saturated) from 38 +/- 0.8 to 58 +/- 1.4 mmHg at 1 h after the start of the infusion. In the 3rd h cardiac output fell significantly from a control value of 358 +/- 33 to 243 +/- 24 ml.kg-1.min-1 and total peripheral resistance significantly increased from 0.31 +/- 0.03 to 0.43 +/- 0.04 mmHg.ml-1.kg.min. Cardiac output and P50 returned toward control over the next few hours. Neither cardiac output nor total peripheral resistance changed in the group of rats receiving vehicle alone. In a separate group of rats, iliac flow decreased significantly to 60% of control and iliac resistance increased to 160% of control. Iliac flow increased significantly in the group of rats that received vehicle only. Although the mechanism of these changes has not been established, these results suggest that a decreased O2 affinity leads to an increased total peripheral resistance and regional vascular resistance and support the hypothesis that O2 plays a role in the metabolic autoregulation of blood flow.


This article has been cited by other articles:


Home page
Anesth. Analg.Home page
J. A. Wahr, M. Gerber, J. Venitz, and N. Baliga
Allosteric Modification of Oxygen Delivery by Hemoglobin
Anesth. Analg., March 1, 2001; 92(3): 615 - 620.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. S. Kilgore, C. F. Shwartz, M. A. Gallagher, R. P. Steffen, R. S. Mosca, and S. F. Bolling
RSR13, a Synthetic Allosteric Modifier of Hemoglobin, Improves Myocardial Recovery Following Hypothermic Cardiopulmonary Bypass
Circulation, November 9, 1999; 100(90002): II-351 - 356.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
O. Eichelbronner, A. Sielenkamper, M. D'Almeida, C. G. Ellis, W. J. Sibbald, and I. H. Chin-Yee
Effects of FIO2 on hemodynamic responses and O2 transport during RSR13-induced reduction in P50
Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H290 - H298.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. S. Pagel, D. A. Hettrick, M. W. Montgomery, J. R. Kersten, R. P. Steffen, and D. C. Warltier
RSR13, a Synthetic Modifier of Hemoglobin-Oxygen Affinity, Enhances the Recovery of Stunned Myocardium in Anesthetized Dogs
J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 1 - 8.
[Abstract] [Full Text]


Home page
J. Appl. Physiol.Home page
R. S. Richardson, K. Tagore, L. J. Haseler, M. Jordan, and P. D. Wagner
Increased VO2 max with right-shifted Hb-O2 dissociation curve at a constant O2 delivery in dog muscle in situ
J Appl Physiol, March 1, 1998; 84(3): 995 - 1002.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online